On October 18, 2018 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer reported that it will present strategies for broad-based or basket clinical trials in lung cancer (Press release, Andarix Pharmaceuticals, OCT 25, 2018, View Source [SID1234530129]). The presentation will take place at the CBI Basket and Umbrella Trials for OncologyConference in Philadelphia, Pennsylvania on Oct 17-18, 2018.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!